David Lawrence

2006

In 2006, David Lawrence earned a total compensation of $628.7K as Chief Financial Officer at Acorda Therapeutics.

Compensation breakdown

Bonus$95,000
Option Awards$173,268
Salary$204,000
Stock Awards$156,456
Total$628,724

Lawrence received $204K in salary, accounting for 32% of the total pay in 2006.

Lawrence also received $95K in bonus, $173.3K in option awards and $156.5K in stock awards.

Rankings

In 2006, David Lawrence's compensation ranked 4,119th out of 7,022 executives tracked by ExecPay. In other words, Lawrence earned more than 41.3% of executives.

ClassificationRankingPercentile
All
4,119
out of 7,022
41st
Division
Manufacturing
1,372
out of 2,413
43rd
Major group
Chemicals And Allied Products
338
out of 673
50th
Industry group
Drugs
228
out of 518
56th
Industry
Biological Products, Except Diagnostic Substances
45
out of 112
60th
Source: SEC filing on April 30, 2009.

Lawrence's colleagues

We found four more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2006.

2006

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2006

Mary Fisher

Acorda Therapeutics

Chief Operating Officer

2006

Andrew Blight

Acorda Therapeutics

Chief Scientific Officer

2006

Jane Wasman

Acorda Therapeutics

General Counsel

News

You may also like